Indication

Immune Dysregulation Disorder

1 clinical trial

1 product

Clinical trial

An Observational Study on the Efficacy and Safety of the Combination Regimen Based on Eravacycline in the Treatment of Multidrug-resistant Bacterial Infections in Immunocompromised Host Populations.

Status: Not yet recruiting, Estimated PCD: 2025-12-31

Product